53449-18-6

Upstream product

• 863216-51-7 C₈H₇N₃O₂ 
• 77287-34-4 formamide 
• 10351-75-4 1H-benzimidazole-5,6-dicarboxylic acid 
• 582-60-5 5,6-dimethyl-1H-benzo[d]imida-zole 
• 3473-63-0 formamidine acetic acid 
• 108451-45-2 1-acetylbenzimidazole-5,6-dicarboxylic anhydride 

Downstream Products

• 53974-23-5 imidazo<4,5-g>quinazoline 
• 115419-99-3 4,9-dihydro-lin-benzohypoxanthine 
• 53449-19-7 8-mercaptoimidazo<4,5-g>quinazoline 
• 53449-20-0 8-methylthioimidazo[4,5-g]-quinazoline 
• 130148-58-2 4-<(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)amino>imidazo<4,5-g>quinazolin-8(3H,7H)-one 

Relevant academic research and scientific papers

Quinazoline derivatives and therapeutic use thereof

Quinazoline derivatives represented by the general formula pharmacologically acceptable salts thereof, and compositions containing such compounds are described. Methods for using the compounds for treatment of hyperproliferative disorders are also described.

Toward a New Genetic System with Expanded Dimensions: Size-Expanded Analogues of Deoxyadenosine and Thymidine

We describe the design, preparation, and properties of two key building blocks of a size-expanded genetic system. Nucleoside analogues of the natural nucleosides dA and dT are reported in which the fusion of a benzo ring increases their size by ca. 2.4 A.